<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">CPJ</journal-id>
<journal-id journal-id-type="hwp">spcpj</journal-id>
<journal-id journal-id-type="nlm-ta">Clin Pediatr (Phila)</journal-id>
<journal-title>Clinical Pediatrics</journal-title>
<issn pub-type="ppub">0009-9228</issn>
<issn pub-type="epub">1938-2707</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0009922811401654</article-id>
<article-id pub-id-type="publisher-id">10.1177_0009922811401654</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Brief Reports</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>A Case of Pyomyositis due to <italic>Escherichia coli</italic> in a 14-Year-Old With Aplastic Anemia</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Van Nielen</surname><given-names>Dominic</given-names></name>
<degrees>DO</degrees>
<xref ref-type="aff" rid="aff1-0009922811401654">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Taggart</surname><given-names>Jerald Luke</given-names></name>
<degrees>DO</degrees>
<xref ref-type="aff" rid="aff1-0009922811401654">1</xref>
</contrib>
</contrib-group>
<aff id="aff1-0009922811401654"><label>1</label>Tulane University, New Orleans, LA, USA</aff>
<author-notes>
<corresp id="corresp1-0009922811401654">Jerald Luke Taggart, Tulane University, 1430 Tulane Avenue, SL 37, New Orleans, LA 70112, USA Email: <email>jltaggart@gmail.com</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>3</month>
<year>2012</year>
</pub-date>
<volume>51</volume>
<issue>3</issue>
<fpage>288</fpage>
<lpage>290</lpage>
<permissions>
<copyright-statement>© SAGE Publications 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
</article-meta>
</front>
<body>
<sec id="section1-0009922811401654" sec-type="intro">
<title>Introduction</title>
<p><italic>Escherichia coli</italic> is a versatile microorganism and an essential normal flora of the human intestinal track; however, it can also be extremely pathogenic with virulence factors affecting a wide range of cellular processes. Fortunately, serious disease due to <italic>E coli</italic> is often limited to immunocompromised hosts.<sup><xref ref-type="bibr" rid="bibr1-0009922811401654">1</xref></sup> <italic>E coli</italic> is the most common cause of gram-negative bacteremia<sup><xref ref-type="bibr" rid="bibr2-0009922811401654">2</xref></sup> and has been well documented to cause diarrhea, meningitis, peritonitis, urinary tract infection, renal or other intra-abdominal abscess, and sepsis.<sup><xref ref-type="bibr" rid="bibr3-0009922811401654">3</xref></sup> It has rarely been described in infections such as pyomyositis, particularly in the lower extremity.<sup><xref ref-type="bibr" rid="bibr4-0009922811401654">4</xref></sup> We describe a 14-year-old patient with severe aplastic anemia (SAA) and neutropenia who developed pyomyositis and soft tissue abscess of the right lower extremity caused by <italic>E coli</italic>.</p>
</sec>
<sec id="section2-0009922811401654" sec-type="cases">
<title>Case Report</title>
<p>A 14-year-old adolescent male with aplastic anemia secondary to Epstein–Barr virus presented with a 1-month history of progressive anterior right lower extremity pain located just distal to the knee. It was sharp, constant, and radiated proximally. He had subjective fever, but no erythema, ecchymosis, or edema was present. Outpatient workup 1 week after symptom onset did not reveal an obvious source of his fever or pain, and he was given pain medications that provided minimal relief.</p>
<p>Over the following weeks, his pain progressively worsened and was associated with new swelling at the site, which was addressed at a hematology clinic evaluation. Lower extremity radiographs were unremarkable and ultrasound at the site of pain was suspicious for blood or infection. A follow-up magnetic resonance imaging scan revealed a small necrotic mass centering the extensor hallucis longus muscle of the right lower extremity and extensive surrounding inflammation involving the entire anterior tibial compartment, suspicious for pyomyositis with abscess formation (<xref ref-type="fig" rid="fig1-0009922811401654">Figures 1</xref> and <xref ref-type="fig" rid="fig2-0009922811401654">2</xref>). No bone involvement was noted.</p>
<fig id="fig1-0009922811401654" position="float">
<label>Figure 1.</label>
<caption>
<p>Magnetic resonance imaging scan demonstrating right lower extremity findings consistent with pyomyositis</p>
</caption>
<graphic xlink:href="10.1177_0009922811401654-fig1.tif"/>
</fig>
<fig id="fig2-0009922811401654" position="float">
<label>Figure 2.</label>
<caption>
<p>Magnetic resonance imaging scan of the right lower extremity demonstrating soft tissue abscess</p>
</caption>
<graphic xlink:href="10.1177_0009922811401654-fig2.tif"/>
</fig>
<p>The patient was subsequently admitted for treatment, now 4 weeks after his pain began. He was afebrile with exam findings significant for soft tissue swelling, erythema, and point tenderness of the anterior right lower extremity just lateral to the tibial tuberosity. Laboratory evaluation revealed a white blood cell count of 0.56 × 10<sup>3</sup>, 12 segmented neutrophils, 2 bands (absolute neutrophil count 78), hemoglobin of 5.4 × 10<sup>3</sup>, and platelets of 6 × 10<sup>3</sup>.</p>
<p>Initial management included vancomycin, pipericillin-tazobactam, and gentamicin, as well as surgical debridement, which revealed purulent material present in the anterior compartment extending deep to the muscle. Cultures returned positive for <italic>E coli</italic>, and antimicrobial coverage was narrowed to ceftriaxone based on susceptibility. He completed a 4-week course with complete resolution of the infection.</p>
</sec>
<sec id="section3-0009922811401654" sec-type="discussion">
<title>Discussion</title>
<p>Abscess formation is characterized by supperative or purulent inflammation due to bacterial invasion causing purulent fluid collection in a tissue, an organ, or a confined space.<sup><xref ref-type="bibr" rid="bibr5-0009922811401654">5</xref>(pp76-78)</sup> The exudate is a collection of neutrophils, macrophages, necrotic cells, and engulfed bacteria.<sup><xref ref-type="bibr" rid="bibr5-0009922811401654">5</xref>(pp76-78),<xref ref-type="bibr" rid="bibr6-0009922811401654">6</xref></sup> To delay extension of the infection, initial immune response serves to “wall off” the injured area of the body with fibrinogen clots.<sup><xref ref-type="bibr" rid="bibr6-0009922811401654">6</xref></sup></p>
<p>As neutrophils serve as one of the primary immune cells in this response and a major component of “pus,” it is not surprising that neutropenic patients may lack the number of neutrophils needed to mount an adequate defense. Also, they commonly will not form purulent inflammation at the site of infection even in the presence of typical pyogenic bacteria (eg, <italic>Staphylococcus aureus</italic>).</p>
<p>Abscess formation is usually an infection of normal body flora residing close to the site. As <italic>E coli</italic> is an essential component of the normal human gut flora, the majority of <italic>E coli</italic> abscesses are abdominal (along with <italic>Peptostreptococcus</italic> and <italic>Clostridium</italic> species).<sup><xref ref-type="bibr" rid="bibr5-0009922811401654">5</xref>(p393)</sup><italic>E coli</italic>, like all Enterobacteriaceae, is a gram-negative rod containing a lipopolysaccharide cell envelope<sup><xref ref-type="bibr" rid="bibr7-0009922811401654">7</xref></sup> and a wide variety of adhesion proteins (pili) and toxins capable of causing significant pathology in humans.<sup><xref ref-type="bibr" rid="bibr3-0009922811401654">3</xref></sup> Extraintestinal pathogenic <italic>E coli</italic> can cause infections at a wide variety of anatomical sites, including the urinary tract, bloodstream, meninges, lungs, and other organs and tissues.<sup><xref ref-type="bibr" rid="bibr4-0009922811401654">4</xref></sup> <italic>E coli</italic> sepsis, in particular, is associated with significant morbidity, mortality, and increased health care expenses, costing between 1.1 and 2.8 billion dollars and causing an estimated 40 000 deaths per year.<sup><xref ref-type="bibr" rid="bibr8-0009922811401654">8</xref></sup></p>
<p>Pyomyositis, an acute primary bacterial infection in skeletal muscles, is caused by <italic>Staph aureus</italic> or other gram-positive organisms in &gt;90% cases.<sup><xref ref-type="bibr" rid="bibr4-0009922811401654">4</xref>,<xref ref-type="bibr" rid="bibr9-0009922811401654">9</xref>,<xref ref-type="bibr" rid="bibr10-0009922811401654">10</xref></sup> Multiple abscesses occur in up to 50% of cases of primary pyomyositis and are not associated with any superficial injury such as puncture, hematoma, or foreign body.<sup><xref ref-type="bibr" rid="bibr11-0009922811401654">11</xref></sup> Historically, pyomyositis has been a disease of tropical climates, but recently there have been an increased number of cases in temperate climates reported, where it is currently responsible for only 1 per 3000 pediatric admissions.<sup><xref ref-type="bibr" rid="bibr12-0009922811401654">12</xref></sup> Nonspecific presenting symptoms and associated conditions such as cellulitis, fasciitis, or underlying periosteal reaction, coupled with clinician inexperience with the disease often delays diagnosis.<sup><xref ref-type="bibr" rid="bibr4-0009922811401654">4</xref>,<xref ref-type="bibr" rid="bibr9-0009922811401654">9</xref>,<xref ref-type="bibr" rid="bibr10-0009922811401654">10</xref>,<xref ref-type="bibr" rid="bibr13-0009922811401654">13</xref></sup> Prompt recognition and treatment initiation is essential to prevent complications such as compartment syndrome, extension into and destruction of an adjacent joint, sepsis, and death.<sup><xref ref-type="bibr" rid="bibr7-0009922811401654">7</xref></sup></p>
<p><italic>E coli</italic> pyomyositis is a rare clinical syndrome that has recently begun to emerge as an increasingly common disease in North America, particularly among patients who are severely immunocompromised.<sup><xref ref-type="bibr" rid="bibr14-0009922811401654">14</xref></sup> Through 2010, the literature has only contained a few case reports of pyomyositis due to <italic>E coli</italic>, all of which have presented in patients with AIDS/HIV<sup><xref ref-type="bibr" rid="bibr14-0009922811401654">14</xref>,<xref ref-type="bibr" rid="bibr15-0009922811401654">15</xref></sup> or with hematologic malignancy.<sup><xref ref-type="bibr" rid="bibr16-0009922811401654">16</xref></sup> Although pyomyositis in general has been reported to have only a 1% mortality rate in immunocompetent hosts,<sup><xref ref-type="bibr" rid="bibr16-0009922811401654">16</xref></sup> there has been a calculated associated mortality of 33% in pyomyositis due to <italic>E coli</italic>.<sup><xref ref-type="bibr" rid="bibr4-0009922811401654">4</xref></sup></p>
<p>This case demonstrates the importance of the high index of suspicion needed by clinicians when diagnosing infections in a neutropenic patient as well as the need for broad-spectrum antibiotic coverage until an organism is isolated. It is unusual to find <italic>E coli</italic> as the primary pathogen in a soft tissue abscess in the lower extremity, especially in a 14-year-old. In a recent retrospective analysis of primary pyomyositis in children, <italic>Staph aureus</italic> and group A <italic>Streptococcus</italic> were the primary microbes responsible for pyogenic tissue abscess.<sup><xref ref-type="bibr" rid="bibr13-0009922811401654">13</xref></sup> To our knowledge, this has been the only reported case of <italic>E coli</italic> pyomyositis in a patient with severe aplastic anemia and is another example of the increasing incidence of <italic>E coli</italic> pyomyositis in North America.</p>
<p>Patients who are immunocompromised are particularly susceptible to infectious pyomyositis<sup><xref ref-type="bibr" rid="bibr7-0009922811401654">7</xref></sup> and infection due to <italic>E coli</italic> in general.<sup><xref ref-type="bibr" rid="bibr1-0009922811401654">1</xref></sup> Our patient’s immunocompromised state was secondary to aplastic anemia—an acquired condition in which hematopoiesis fails, most likely because of active destruction of blood-forming cells by lymphocytes leading to a decrease in erythrocytes, granulocytes, and platelets.<sup><xref ref-type="bibr" rid="bibr17-0009922811401654">17</xref></sup> The resulting hypocellular bone makes these patients both more susceptible to bacterial infections and also more problematic to treat. The leukocyte count will rise and fall frequently as a result of the disease process and treatment regimen. It is possible a low absolute neutrophil count at the time of his initial presentation led to the nonspecific exam findings described and a delay in the diagnosis of pyomyositis. A rise in the neutrophil count sometime over this 4-week period prior to admission likely allowed adequate immune response and formation of purulent inflammation at the site, which was revealed during surgical debridement.</p>
<p>Pyomyositis should remain part of the differential diagnosis for extremity pain or signs of soft tissue infection, with or without purulent inflammation, especially in the immunocompromised host. In addition, initial antimicrobial coverage in this setting should be expanded to include gram-negative organisms. Early recognition and often surgical intervention is essential in preventing the spread of the infection and corresponding morbidity and mortality associated with pyomyositis.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="conflict">
<p>The authors declared no potential conflicts of interests with respect to the authorship and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure">
<p>The authors received no financial support for the research and/or authorship of this article.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0009922811401654">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Klastersky</surname><given-names>J</given-names></name>
<name><surname>Ameye</surname><given-names>L</given-names></name>
<name><surname>Maertens</surname><given-names>J</given-names></name>
<etal/>
</person-group>. <article-title>Bacteraemia in febrile neutropenic cancer patients</article-title>. <source>Int J Antimicrob Agents</source>. <year>2007</year>;<volume>30</volume>(<supplement>Suppl 1</supplement>):<fpage>S51</fpage>-<lpage>S59</lpage>.</citation>
</ref>
<ref id="bibr2-0009922811401654">
<label>2.</label>
<citation citation-type="book">
<person-group person-group-type="editor">
<name><surname>Wisplinghoff</surname><given-names>H</given-names></name>
<name><surname>Bischoff</surname><given-names>T</given-names></name>
<name><surname>Tallent</surname><given-names>SM</given-names></name>
<name><surname>Seifert</surname><given-names>H</given-names></name>
<name><surname>Wenzel</surname><given-names>RP</given-names></name>
<name><surname>Edmon</surname><given-names>MB</given-names></name>
</person-group>. <article-title>Nosocomial bloodstream infections in U.S. hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study</article-title>. <source>Clin Infect Dis</source>. <year>2004</year>;<volume>39</volume>:<fpage>309</fpage>-<lpage>317</lpage>.</citation>
</ref>
<ref id="bibr3-0009922811401654">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kaper</surname><given-names>JB</given-names></name>
<name><surname>Nataro</surname><given-names>JP</given-names></name>
<name><surname>Mobley</surname><given-names>HL</given-names></name>
</person-group>. <article-title>Pathogenic <italic>Escherichia coli</italic></article-title>. <source>Nat Rev Microbiol</source>. <year>2004</year>;<volume>2</volume>:<fpage>123</fpage>-<lpage>140</lpage>.</citation>
</ref>
<ref id="bibr4-0009922811401654">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Vigil</surname><given-names>KJ</given-names></name>
<name><surname>Johnson</surname><given-names>JR</given-names></name>
<name><surname>Johnston</surname><given-names>BD</given-names></name>
<etal/>
</person-group>. <article-title><italic>Escherichia coli</italic> pyomyositis: An emerging infectious disease among patients with hematologic malignancies</article-title>. <source>Clin Infect Dis</source>. <year>2010</year>;<volume>50</volume>:<fpage>374</fpage>-<lpage>380</lpage>.</citation>
</ref>
<ref id="bibr5-0009922811401654">
<label>5.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Kumar</surname><given-names>V</given-names></name>
<name><surname>Fausto</surname><given-names>N</given-names></name>
<name><surname>Abbas</surname><given-names>A</given-names></name>
</person-group>. <source>Robbins &amp; Cotran Pathologic Basis of Disease</source>. <edition>7th ed.</edition> <publisher-loc>Philadelphia, PA</publisher-loc>: <publisher-name>Elsevier Saunders</publisher-name>; <year>2005</year>. p. <fpage>76</fpage>-<lpage>78</lpage>.</citation>
</ref>
<ref id="bibr6-0009922811401654">
<citation citation-type="book">
<label>6.</label>
<person-group person-group-type="author">
<name><surname>Guyton</surname><given-names>A</given-names></name>
<name><surname>Hall</surname><given-names>J</given-names></name>
</person-group>. <source>Textbook of Medical Physiology</source>. <publisher-loc>Philadelphia, PA</publisher-loc>: <publisher-name>Saunders</publisher-name>, <year>2000</year>. p. <fpage>397</fpage>-<lpage>398</lpage>.</citation>
</ref>
<ref id="bibr7-0009922811401654">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bickels</surname><given-names>J</given-names></name>
<name><surname>Ben-Sira</surname><given-names>L</given-names></name>
<name><surname>Kessler</surname><given-names>A</given-names></name>
<name><surname>Wientroub</surname><given-names>S</given-names></name>
</person-group>. <article-title>Primary pyomyositis</article-title>. <source>J Bone Joint Surg Am</source>. <year>2002</year>;84A:<fpage>2277</fpage>-<lpage>2286</lpage>.</citation>
</ref>
<ref id="bibr8-0009922811401654">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Russo</surname><given-names>TA</given-names></name>
<name><surname>Johnson</surname><given-names>JR</given-names></name>
</person-group>. <article-title>Medical and economic impact of extraintestinal infections due to <italic>Escheria coli</italic>: focus on an increasingly important endemic problem</article-title>. <source>Microbes Infect</source>. <year>2003</year>;<volume>5</volume>:<fpage>449</fpage>-<lpage>456</lpage>.</citation>
</ref>
<ref id="bibr9-0009922811401654">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Harrington</surname><given-names>P</given-names></name>
<name><surname>Scott</surname><given-names>B</given-names></name>
<name><surname>Chetcuti</surname><given-names>P</given-names></name>
</person-group>. <article-title>Multifocal streptococcal pyomyositis complicated by acute compartment syndrome: case report</article-title>. <source>J Pediatr Orthop B</source>. <year>2001</year>;<volume>10</volume>:<fpage>120</fpage>-<lpage>122</lpage>.</citation>
</ref>
<ref id="bibr10-0009922811401654">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mitsionis</surname><given-names>GI</given-names></name>
<name><surname>Manoudis</surname><given-names>GN</given-names></name>
<name><surname>Lykissas</surname><given-names>MG</given-names></name>
<etal/>
</person-group>. <article-title>Pyomyositis in children: early diagnosis and treatment</article-title>. <source>J Pediatr Surg</source>. <year>2009</year>;<volume>44</volume>:<fpage>2173</fpage>-<lpage>2178</lpage>.</citation>
</ref>
<ref id="bibr11-0009922811401654">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Christin</surname><given-names>L</given-names></name>
<name><surname>Sarosi</surname><given-names>GA.</given-names></name>
</person-group> <article-title>Pyomyositis in North America: case reports and review</article-title>. <source>Clin Infect Dis</source>. <year>1992</year>;<volume>15</volume>:<fpage>668</fpage>-<lpage>677</lpage>.</citation>
</ref>
<ref id="bibr12-0009922811401654">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gibson</surname><given-names>RK</given-names></name>
<name><surname>Rosenthal</surname><given-names>SJ</given-names></name>
<name><surname>Luckert</surname><given-names>BP.</given-names></name>
</person-group> <article-title>Pyomyositis: increasing recognition in temperate climates</article-title>. <source>Am J Med</source>. <year>1984</year>;<volume>77</volume>:<fpage>762</fpage>-<lpage>772</lpage>.</citation>
</ref>
<ref id="bibr13-0009922811401654">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ovadia</surname><given-names>D</given-names></name>
<name><surname>Ezra</surname><given-names>E</given-names></name>
<name><surname>Ben-Sira</surname><given-names>L</given-names></name>
<etal/>
</person-group>. <article-title>Primary pyomyositis in children: a retrospective analysis of 11 cases</article-title>. <source>J Pediatr Orthop B</source>. <year>2007</year>;<volume>16</volume>:<fpage>153</fpage>-<lpage>159</lpage>.</citation>
</ref>
<ref id="bibr14-0009922811401654">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Vilades</surname><given-names>C</given-names></name>
<name><surname>Garcia-Queralt</surname><given-names>R</given-names></name>
<name><surname>Rivas</surname><given-names>I</given-names></name>
<name><surname>Vidal</surname><given-names>F</given-names></name>
<name><surname>Richart</surname><given-names>C.</given-names></name>
</person-group> <article-title>Pyomyositis due to <italic>Escherichia coli</italic> in patient infected by HIV</article-title>. <source>Br J Rheumatol</source>. <year>1994</year>;<volume>33</volume>:<fpage>404</fpage>-<lpage>405</lpage>.</citation>
</ref>
<ref id="bibr15-0009922811401654">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lortholary</surname><given-names>O</given-names></name>
<name><surname>Jehl</surname><given-names>F</given-names></name>
<name><surname>Petitjean</surname><given-names>O</given-names></name>
<name><surname>Cohen</surname><given-names>P</given-names></name>
<name><surname>Tarral</surname><given-names>E</given-names></name>
<name><surname>Gullevin</surname><given-names>L</given-names></name>
</person-group>. <article-title>Polymicrobial pyomyositis and bacteremia in a patient with AIDS</article-title>. <source>Clin Infect Dis</source>. <year>1994</year>;<volume>19</volume>:<fpage>552</fpage>-<lpage>553</lpage>.</citation>
</ref>
<ref id="bibr16-0009922811401654">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Crum</surname><given-names>NF</given-names></name>
</person-group>. <article-title>Bacterial pyomyositis in the United States</article-title>. <source>Am J Med</source>. <year>2004</year>;<volume>117</volume>:<fpage>420</fpage>-<lpage>428</lpage>.</citation>
</ref>
<ref id="bibr17-0009922811401654">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Young</surname><given-names>N</given-names></name>
</person-group>. <article-title>Acquired aplastic anemia</article-title>. <source>Ann Intern Med</source>. <year>2002</year>;<volume>137</volume>: <fpage>534</fpage>-<lpage>546</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>